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Abstract 
 
Vascular function has been found to be impaired in patients with sickle cell disease (SCD). 
The present study investigated the determinants of systemic vascular resistance in two main 
SCD syndromes in children: sickle cell anemia (SCA) and sickle cell-hemoglobin C disease 
(SCC). Nitric oxide metabolites (NOx), hematological, hemorheological, and hemodynamical 
parameters were investigated in 61 children with SCA and 49 children with SCC. While mean 
arterial pressure was not different between SCA and SCC children, systemic vascular 
resistance (SVR) was greater in SCC children. Although SVR and blood viscosity (b) were 
not correlated in SCC children, the increase of b (+18%) in SCC children compared to SCA 
children results in a greater mean SVR in this former group. SVR was positively correlated 
with b, hemoglobin (Hb) level and RBC deformability, and negatively with NOx level in 
SCA children. Multivariate linear regression model showed that both NOx and Hb levels were 
independently associated with SVR in SCA children. In SCC children, only NOx level was 
associated with SVR. In conclusion, vascular function of SCC children seems to better cope 
with higher b compared to SCA children. Since the occurrence of vaso-occlusive like 
complications are less frequent in SCC than in SCA children, this finding suggests a 
pathophysiological link between the vascular function alteration and these clinical 
manifestations. In addition, our results suggested that nitric oxide metabolism plays a key role 
in the regulation of SVR, both in SCA and SCC.  
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Introduction  
 
Sickle cell disease (SCD) patients are characterized by wide hemorheological alterations [36], 
which participate to the pathophysiological mechanisms of vaso-occlusion [1, 27, 32]. Sickle 
cell anemia (SCA) and sickle cell hemoglobin C disease (SCC) are the most frequent forms of 
SCD but they drastically differ in their hemorheological profile [36]. SCC patients usually 
exhibit moderate anemia as compared to SCA patients, a characteristic which explains why 
they exhibit blood hyper-viscosity in comparison with SCA patients or control population 
[36]. In the traditional view, it has long been postulated that conditions in which blood 
viscosity (b) is increased should be associated with increased vascular resistance and 
decreased tissue perfusion [11, 17]. 
The study of the relationship between b and systemic vascular resistance (SVR) may provide 
relevant information on the vascular function [15-16, 22, 39]. Counterintuitive data have been 
recently reported in animal models demonstrating that increment in b resulted in a 
paradoxical decrease of vascular resistance. This observation demonstrates that vascular 
function, if not impaired, is able to adapt to increased b, until a certain threshold, and thus 
modulating SVR [12-14]. Although some data support an impaired vascular function in SCA 
patients [6, 18], the vascular function of SCC patients has been poorly described up to now. 
We propose, in the present study, to explore the relationships between b and SVR in a group 
of SCA children and a group of SCC children. Since patients with SCC, despite their very 
high b [36], present an usually milder clinical course of the disease than SCA patients [26], 
we hypothesized that SVR should be less dependent on b in SCC patients than in SCA 
patients, indicating more preserved vascular control mechanisms in the former group than in 
the latter one.  
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In addition, it has been shown that nitric oxide (NO) metabolism is impaired in SCA [21] and 
may play a key role in the regulation of vascular function [6]. To our best knowledge, no 
study had investigated NO production in SCC so far. We tested the association of nitric oxide 
metabolites (NOx) level with SVR and we hypothesized that NO production should be lower 
in SCA than in SCC children.  
 
Methods 
 
Patients and Ethics statement  
A total of 110 children with SCD aged from 8 to 16 yrs old were included in the study: 61 
with SCA and 49 with SCC. All these children had been identified by neonatal sickle cell 
disease screening and thus have benefited, since birth, of medical follow-up at the Sickle Cell 
Center of the Academic Hospital of Pointe-à-Pitre (Guadeloupe). All of them were in steady-
state condition at the time of their recruitment. The diagnosis of SCD was established by 
isoelectrofocusing (Multiphor II™ System, GE HEALTH CARE, Buck, UK), citrate agar 
electrophoresis, cation-exchange high performance liquid chromatography (VARIANT™, 
Bio-Rad Laboratories, Hercules, CA, USA) and confirmed by DNA studies for the SCA 
children [35]. Steady state was defined as a period without blood transfusions within the 
previous three months and the absence of acute episodes (infection, vaso-occlusive crisis, 
acute chest syndrome, stroke, priapism, splenic sequestration) for at least one month before 
enrolment in the study. Twenty-three percents of the SCA patients were under hydroxyurea 
(HU) therapy while no SCC patients received HU. NOx level, hemodynamical, 
hemorheological and hematological parameters were determined in all children. The painful 
vaso-occlusive (VOC) and acute chest syndrome (ACS) rates were calculated for each child 
by dividing the number of painful VOC or ACS episodes by the number of patient-years [32]. 
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An acute event was scored as a VOC or ACS using the criteria previously published [20]. All 
the information regarding the VOC or ACS episodes have been collected retrospectively and 
independently by three physicians who were not aware of the biological and hemodynamical 
results.  
 
The protocol was in accordance with the guidelines set by the Declaration of Helsinki and was 
approved by the Regional Ethics Committee (CPP Sud/Ouest Outre Mer III, Bordeaux, 
France; SAPOTILLE project, IRB number: 2009-A00211-56). All children were informed of 
the procedures and purposes of the study and all, as well as their parents, gave written 
informed consent.  
 
Biological measurements 
Venipuncture was performed between 8:00 a.m. and 10:00 a.m. EDTA blood samples were 
immediately used for measurements of hemoglobin concentration (Hb), hematocrit (Hct), 
mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), percent of 
reticulocytes (RET), and red blood cell (RBC), platelet (PLT) and white blood cell (WBC) 
counts (Max M-Retic, Coulter, USA). The b was determined at native Hct, at 25°C and at a 
shear rate of 225 s
−1
 using a cone-plate viscometer (Brookfield DVII+ with CPE40 spindle, 
Brookfield Engineering Labs, Natick, MA). RBC deformability (Elongation Index; EI) was 
determined at 37°C and at 30 Pa by ektacytometry, using the Laser-assisted Optical 
Rotational Cell Analyzer (LORCA, RR Mechatronics, Hoorn, the Netherlands). 
Measurements were carried out within 4 hours following venipuncture to avoid blood 
rheological alterations [38]. Full oxygenation of blood was performed before the 
measurements using the methodological procedures recommended [4]. NOx levels were 
determined by measuring plasma concentrations of nitrate/nitrite (after the conversion of 
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nitrate to nitrite utilizing nitrate reductase) with a colorimetric assay kit (Enzo Life Sciences, 
Villeurbanne, France). 
 
Hemodynamical parameters 
Systolic (SBP) and diastolic blood pressures (DBP) were manually measured at the brachial 
artery level and mean arterial pressure (MAP) was then calculated as: [(2 * DBP) + SBP] / 3. 
Hemodynamical parameters were assessed by transthoracic echocardiography using Sonos 
IE33 machines (Philips Medical Systems, Andover, MA, USA). Heart rate (HR), stroke 
volume (SV) and cardiac output were determined. The cardiac output was corrected by the 
body surface for determination of the cardiac index (CI). Systemic vascular resistance (SVR) 
was then calculated by dividing MAP by CI and expressed in Wood Unit (WU). Since no 
right heart catheterization was possible in this study, SVR calculation did not take into 
account the right atrial pressure (i.e. central venous pressure), which is usually estimated to be 
around 5-10 mmHg in this population [29, 31].  
 
Statistical analysis 
Results are presented as means ± SD. Biological and hemodynamical parameters were 
compared between SCA and SCC children using an unpaired Student t test. Correlation 
analyses were performed using a Pearson test in the SCA and SCC groups. The significance 
level was defined as p < 0.05. Significant associations found between SVR and biological 
parameters for each group were then included in a multivariate linear regression model to test 
the independent associations between SVR and the biological variables. Analyses were 
conducted using Statistica (v. 5.5, Statsoft, USA). 
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Results 
Anthropometric characteristics and acute complications 
Mean age (11.5 ± 2.4 yrs and 12.0 ± 2.3 yrs in SCA and SCC children, respectively) and 
height (147 ± 15 cm and 153 ± 16 cm in SCA and SCC children, respectively) were not 
different between the two groups. SCA children (37.4 ± 11.6 kg) had lower weight than SCC 
children (44.8 ± 14.5 kg; p < 0.01). Mean VOC (p < 0.05) and ACS (p < 0.001) rates were 
significantly greater in SCA (0.44 ± 0.48 and 0.15 ± 0.22 episodes/yr, respectively) than in 
SCC children (0.26 ± 0.39 and 0.03 ± 0.06 episodes/yr, respectively). 
 
Biological parameters 
As expected, WBC and PLT counts, MCV, MCH, and RET values were higher in SCA 
children than in SCC children (p < 0.001; Table 1) while RBC count, Hb, Hct, b, RBC 
deformability (AI) and NOx levels were lower in the SCA group than in the SCC group (p < 
0.01 or < 0.001; Table 1). 
 
Hemodynamical parameters 
Hemodynamical parameters are reported in the Table 2. Because SBP and DBP were not 
different between the two groups, MAP was similar in the SCA and SCC children (Table 2). 
Both SV (p < 0.01) and HR (p < 0.05) were greater in SCA children than in SCC children 
resulting in a greater CI (p < 0.001). SVR was lower in SCA patients compared to the SCC 
group (p < 0.001).  
 
Correlation analyses 
Significant positive correlations were observed between SVR and b, Hb level or RBC 
deformability in the SCA group (r = 0.31, p < 0.05, Figure 1a; r = 0.63, p < 0.001, Figure 2a; r 
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= 0.33, p < 0.05, Figure 3a, respectively) but not in the SCC group (r = 0.06, p > 0.05; Figure 
1b; r = -0.28, p > 0.05, Figure 2b; r = 0.03, p > 0.05, Figure 3b, respectively). Significant 
negative correlations were found in both SCA and SCC group between SVR and NOx (r = -
0.32, p < 0.05, Figure 4a; r = -0.36, p < 0.05, Figure 4b, respectively). No significant 
correlation was observed between SVR and RET. 
 
Multivariate linear regression model 
In SCA children, the multivariate linear regression model included SVR as dependent variable 
and b, Hb level, RBC deformability and NOx level as covariates. The overall model was 
statistically significant (R² = 0.55; p < 0.001) and only Hb and NOx levels remained 
significantly associated with SVR (beta = 0.74, p < 0.001 and beta = -0.30, p < 0.05, 
respectively). No multivariate linear regression model was performed in the SCC children 
since only SVR and NOx levels were associated (see above).  
 
Discussion  
The major findings of the present study are that 1) SCA children are characterized by lower 
Hb level, b and SVR than SCC children suggesting lower vascular stress in SCA than in 
SCC children but 2) SVR is positively correlated with b in SCA children and not in the SCC 
group demonstrating that the vascular system is able to better cope with high b in SCC than 
in SCA children to maintain SVR at a constant level. Finally, nitric oxide metabolism seems 
to be involved in the regulation of SVR in both SCA and SCC children. 
 
As previously shown, the hematological and hemorheological characteristics of SCC and 
SCA children included in this study shown significant differences [2, 10, 20, 36] with marked 
anemia, leucocytosis, reticulocytosis, thrombocytosis, lower b at native hematocrit and 
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reduced RBC deformability in the SCA group. Although SCC children had a 18% fold greater 
b and 27% fold greater SVR than SCA children, the two groups exhibited same SBP and 
DBP leading to similar MAP. This finding results from the fact that CI, as a consequence of 
severe anemia, was higher in SCA children in comparison with SCC children.  
  
In healthy population, vascular geometry adapts to compensate for increased b, hence 
limiting the increase in SVR [28, 33, 39]. A rise in b has been shown to increase the wall 
shear stress applied to the endothelium level, which produces more vasodilators, such as NO, 
leading to compensatory vasodilation [8, 34, 37, 39]. Vazquez et al. [39] demonstrated that, in 
healthy controls, SVR and b were not correlated which strongly supports the concept that 
vascular function may easily compensate for the increase in b in healthy individuals. Since 
SCC children have elevated b and SVR compared to SCA group, it could be suggested that 
vascular function is more impaired in SCC children than in SCA children. But the positive 
correlation found between SVR and b in the SCA group only, suggests that vascular 
function is more impaired in SCA than in SCC; a situation also described in type 1 diabetes 
children [39]. Indeed, although the vascular stress is higher in SCC children (greater SVR), 
their vascular system is better able to cope with increased blood viscosity than in SCA 
children. Besides, a recent study performed on a subgroup of SCA and SCC children included 
in this study demonstrated that increased blood viscosity was a risk factor for VOC in SCA 
but not in SCC children [20]. In addition, Mohan et al. [23] reported that endothelium-
dependent cutaneous vasodilation at the finger level was more impaired in SCA than in SCC 
disease suggesting, again, greater vascular dysfunction in SCA than in SCC.  
 
Our results also demonstrated a negative correlation between SVR and NOx level, and 
positive correlations between SVR and Hb level or RBC deformability in SCA children. 
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While it seems logic that lower NO production and higher Hb level (causing higher b) could 
induce greater SVR, the physiological meaning of the positive association between RBC 
deformability and SVR clearly deserves further explanation. Several experimental data have 
demonstrated that improved RBC deformability may cause a decrease of vascular resistance 
and facilitates blood flow [5, 30]. A decrease of RBC deformability may affect RBC velocity 
in the microcirculation, particularly when the blood pressure is lowered [9]. However, in the 
context of SCA [40], it is demonstrated that well deformable RBCs abnormally adhere to 
endothelial cells [24], hence impairing blood flow [19] and triggering VOC [3, 20]. 
Accordingly, the association between RBC deformability and SVR found in SCA children is 
not so surprising. Then, the multivariate linear regression analysis demonstrated that both Hb 
and NOx were independently associated with SVR in SCA children showing that both of 
these parameters play an independent and important role in determining SVR.  
While neither b, nor Hb level was associated with SVR in SCC children, increased NOx 
level was accompanied by decreased SVR. Although the lack of association between SVR 
and b in SCC children suggests a more preserved vascular function in this population than in 
SCA children, their SVR seems to be very sensitive to the amount of NO produced as it is the 
case for SCA children. Any decrease in NO bioavailability caused by hemolysis [18] and 
oxidative stress [7] could be susceptible to increase blood flow resistance in SCC. NOx levels 
have been previously found to be associated with VOC and ACS occurrence in SCA [25]. 
Indeed, the lower NOx level observed in our SCA children compared to the SCC group could 
partly explain why SCA children had an average higher rate of VOC and ACS than SCC 
children. 
 
In conclusion, the present study demonstrated that children with SCA have lower b resulting 
in a lower SVR than children with SCC. However, despite these differences, the vascular 
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function of SCC children seems to be more preserved than the one of SCA children since 
SVR is not correlated with b in SCC children. This observation may provide a partial 
explanation to the lower frequency of the vaso-occlusive clinical complication observed in 
SCC compared to SCA children [26]. Nevertheless, the vascular function of both SCD 
syndromes seems to be sensitive to the amount of nitric oxide produced.  
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Figure 1 
Figure 1a: Relationship between SVR and b in SCA children 
Figure 1b: Relationship between SVR and b in SCC children 
 
Figure 2 
Figure 2a: Relationship between SVR and Hb level in SCA children 
Figure 2b: Relationship between SVR and Hb level in SCC children 
 
Figure 3 
Figure 3a: Relationship between SVR and RBC deformability (EI) in SCA children 
Figure 3b: Relationship between SVR and RBC deformability (EI) in SCC children 
 
Figure 4 
Figure 4a: Relationship between SVR and NOx in SCA children 
Figure 4b: Relationship between SVR and NOx in SCC children 
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Table 1: Hematological parameters and blood viscosity in SCD children 
 SCA 
(n = 61) 
SCC 
(n = 49) 
Hb (g.dl
-1
) 7.9 ± 1.4 11.1 ± 1.0*** 
Hct (%) 23.0 ± 4.3 31.6 ± 2.7*** 
MCV (fl) 81.9 ± 8.4 71.7 ± 5.8*** 
MCH (pg) 28.1 ± 3.2 25.3 ± 2.4*** 
RET (10
9
.l
-1
) 290 ± 117 128 ± 45*** 
RBC (10
12
.l
-1
) 2.8 ± 0.7 4.4 ± 0.5*** 
WBC (10
9
.l
-1
)  11.2 ± 2.9 7.3 ± 2.8*** 
PLT (10
9
.l
-1
) 457 ± 138 282 ± 134*** 
ηb (mPa.s-1) † 5.5 ± 1.4 6.7 ± 1.2*** 
NOx (mol.l-1) †† 28.5 ± 9.7 33.7 ± 10.5** 
EI (AU)
 †††
 0.38 ± 0.11 0.45 ± 0.05*** 
Values are expressed as mean ± SD. Hb (hemoglobin concentration), Hct (hematocrit), MCV 
(mean corpuscular volume), MCH (mean corpuscular hemoglobin), RET (percent of 
reticulocytes), RBC (red blood cell count), WBC (white blood cell count), PLT (platelet 
count), LDH (lactate deshydrogenase), b (blood viscosity), NOx (nitric oxide metabolites) 
and EI (elongation index = RBC deformability). Statistical difference (*p < 0.05; **p < 0.01; 
***p < 0.001). 
†
determined in 57 SCA and 47 SCC, 
††
determined in 56 SCA and 49 SCC, 
†††
determined in 58 SCA and 49 SCC. 
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Table 2: Hemodynamical parameters in SCD children 
 SCA SCC 
SBP (mmHg) 108 ± 8 107 ± 9 
DBP (mmHg) 66 ± 7 67 ± 8 
MAP (mmHg) 94 ± 7 94 ± 7 
SV (ml)
 †
 72.0 ± 19.5 57.6 ± 18.7*** 
HR (beats.min
-1
)
 †
 81 ± 10 74 ± 14* 
CI (l.min
-1
.m
-2
)
 †
 5.8 ± 1.6 4.2 ± 1.1*** 
SVR (AU)
 †
 17.4 ± 4.9 23.8 ± 5.7*** 
Values are expressed as mean ± SD. SBP (systolic blood pressure), DBP (diastolic blood 
pressure), MAP (Mean arterial pressure), SV (stroke volume), HR (heart rate), CI (cardiac 
index), SVR (systemic vascular resistance). Statistical difference (*p < 0.05; **p < 0.01; ***p 
< 0.001). 
†
determined in 49 SCA and 40 SCC 
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